Literature DB >> 25571279

Pulsatile operation of the BiVACOR TAH - Motor design, control and hemodynamics.

Matthias Kleinheyer, Daniel L Timms, Nicholas A Greatrex, Toru Masuzawa, O Howard Frazier, William E Cohn.   

Abstract

Although there is limited consensus about the strict requirement to deliver pulsatile perfusion to the human circulatory system, speed modulation of rotary blood pumps is an approach that may capture the benefits of both positive displacement and continuous flow blood pumps. In the current stage of development of the BiVACOR Total Artificial Heart emphasis is placed on providing pulsatile outflow from the pump. Multiple pulsatile speed profiles have been applied in preliminary in-vivo operation in order to assess the capability of the TAH to recreate a physiologic pulse. This paper provides an overview about recent research towards pulsatile BiVACOR operation with special emphasis on motor and control requirements and developments.

Entities:  

Mesh:

Year:  2014        PMID: 25571279     DOI: 10.1109/EMBC.2014.6944911

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  First report of 90-day support of 2 calves with a continuous-flow total artificial heart.

Authors:  Jamshid H Karimov; Nader Moazami; Mariko Kobayashi; Shiva Sale; Kimberly Such; Nicole Byram; Gengo Sunagawa; David Horvath; Shengqiang Gao; Barry Kuban; Leonard A R Golding; Kiyotaka Fukamachi
Journal:  J Thorac Cardiovasc Surg       Date:  2015-06-18       Impact factor: 5.209

Review 2.  Advancements in mechanical circulatory support for patients in acute and chronic heart failure.

Authors:  Thomas A Csepe; Ahmet Kilic
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  Effects on the pulmonary hemodynamics and gas exchange with a speed modulated right ventricular assist rotary blood pump: a numerical study.

Authors:  Feng Huang; Zhe Gou; Yang Fu; Xiaodong Ruan
Journal:  Biomed Eng Online       Date:  2018-10-20       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.